BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Santarpia M, Liguori A, D'Aveni A, Karachaliou N, Gonzalez-Cao M, Daffinà MG, Lazzari C, Altavilla G, Rosell R. Liquid biopsy for lung cancer early detection. J Thorac Dis 2018;10:S882-97. [PMID: 29780635 DOI: 10.21037/jtd.2018.03.81] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
Number Citing Articles
1 Kalinke L, Thakrar R, Janes SM. The promises and challenges of early non-small cell lung cancer detection: patient perceptions, low-dose CT screening, bronchoscopy and biomarkers. Mol Oncol 2021;15:2544-64. [PMID: 33252175 DOI: 10.1002/1878-0261.12864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Lener MR, Reszka E, Marciniak W, Lesicka M, Baszuk P, Jabłońska E, Białkowska K, Muszyńska M, Pietrzak S, Derkacz R, Grodzki T, Wójcik J, Wojtyś M, Dębniak T, Cybulski C, Gronwald J, Kubisa B, Pieróg J, Waloszczyk P, Scott RJ, Jakubowska A, Narod SA, Lubiński J. Blood cadmium levels as a marker for early lung cancer detection. J Trace Elem Med Biol 2021;64:126682. [PMID: 33249371 DOI: 10.1016/j.jtemb.2020.126682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhou C, Li S, Liu J, Chu Q, Miao L, Cai L, Cai X, Chen Y, Cui F, Dong Y, Dong W, Fang W, He Y, Li W, Li M, Liang W, Lin G, Lin J, Lin X, Liu H, Liu M, Mu X, Hu Y, Hu J, Jin Y, Li Z, Qin Y, Ren S, Sun G, Shen Y, Su C, Tang K, Wu L, Wang M, Wang H, Wang K, Wang Y, Wang P, Wang H, Wang Q, Wang Z, Xie X, Xie Z, Xu X, Xu F, Yang M, Yang B, Yi X, Ye X, Ye F, Yu Z, Yue D, Zhang B, Zhang J, Zhang J, Zhang X, Zhang W, Zhao W, Zhu B, Zhu Z, Zhong W, Bai C, Chen L, Han B, Hu C, Lu S, Li W, Song Y, Wang J, Zhou C, Zhou J, Zhou Y, Saito Y, Ichiki Y, Igai H, Watanabe S, Bravaccini S, Fiorelli A, Petrella F, Nakada T, Solli P, Tsoukalas N, Kataoka Y, Goto T, Berardi R, He J, Zhong N. International consensus on severe lung cancer-the first edition. Transl Lung Cancer Res 2021;10:2633-66. [PMID: 34295668 DOI: 10.21037/tlcr-21-467] [Reference Citation Analysis]
4 El Ayachy R, Giraud N, Giraud P, Durdux C, Giraud P, Burgun A, Bibault JE. The Role of Radiomics in Lung Cancer: From Screening to Treatment and Follow-Up. Front Oncol 2021;11:603595. [PMID: 34026602 DOI: 10.3389/fonc.2021.603595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Herath S, Sadeghi Rad H, Radfar P, Ladwa R, Warkiani M, O’byrne K, Kulasinghe A. The Role of Circulating Biomarkers in Lung Cancer. Front Oncol 2022;11:801269. [DOI: 10.3389/fonc.2021.801269] [Reference Citation Analysis]
6 Müller Bark J, Kulasinghe A, Amenábar JM, Punyadeera C. Exosomes in cancer. Adv Clin Chem 2021;101:1-40. [PMID: 33706886 DOI: 10.1016/bs.acc.2020.06.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zeinali M, Lee M, Nadhan A, Mathur A, Hedman C, Lin E, Harouaka R, Wicha MS, Zhao L, Palanisamy N, Hafner M, Reddy R, Kalemkerian GP, Schneider BJ, Hassan KA, Ramnath N, Nagrath S. High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients. Cancers (Basel) 2020;12:E127. [PMID: 31947893 DOI: 10.3390/cancers12010127] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
8 Benzaquen J, Boutros J, Marquette C, Delingette H, Hofman P. Lung Cancer Screening, Towards a Multidimensional Approach: Why and How? Cancers (Basel) 2019;11:E212. [PMID: 30759893 DOI: 10.3390/cancers11020212] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
9 Chen M, Wu D, Tu S, Yang C, Chen D, Xu Y. CRISPR/Cas9 cleavage triggered ESDR for circulating tumor DNA detection based on a 3D graphene/AuPtPd nanoflower biosensor. Biosens Bioelectron 2020;173:112821. [PMID: 33221510 DOI: 10.1016/j.bios.2020.112821] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
10 Paci E. The narrow path to organized LDCT lung cancer screening programs in Europe. J Thorac Dis 2018;10:4556-64. [PMID: 30174908 DOI: 10.21037/jtd.2018.07.08] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 Smolarz M, Widlak P. Serum Exosomes and Their miRNA Load-A Potential Biomarker of Lung Cancer. Cancers (Basel) 2021;13:1373. [PMID: 33803617 DOI: 10.3390/cancers13061373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Fernandez C, Grills IS, Ye H, Hope AJ, Guckenberger M, Mantel F, Kestin LL, Belderbos J, Werner-Wasik M. Stereotactic Image Guided Lung Radiation Therapy for Clinical Early Stage Non-Small Cell Lung Cancer: A Long-Term Report From a Multi-Institutional Database of Patients Treated With or Without a Pathologic Diagnosis. Pract Radiat Oncol 2020;10:e227-37. [PMID: 31837478 DOI: 10.1016/j.prro.2019.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Li S, Wang Z, Li XJ. Notch signaling pathway suppresses CD8+ T cells activity in patients with lung adenocarcinoma. Int Immunopharmacol 2018;63:129-36. [PMID: 30086535 DOI: 10.1016/j.intimp.2018.07.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
14 Pessoa LS, Heringer M, Ferrer VP. ctDNA as a cancer biomarker: A broad overview. Crit Rev Oncol Hematol. 2020;155:103109. [PMID: 33049662 DOI: 10.1016/j.critrevonc.2020.103109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 Revelo AE, Martin A, Velasquez R, Kulandaisamy PC, Bustamante J, Keshishyan S, Otterson G. Liquid biopsy for lung cancers: an update on recent developments. Ann Transl Med 2019;7:349. [PMID: 31516895 DOI: 10.21037/atm.2019.03.28] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
16 Liu HE, Vuppalapaty M, Wilkerson C, Renier C, Chiu M, Lemaire C, Che J, Matsumoto M, Carroll J, Crouse S, Hanft VR, Jeffrey SS, Di Carlo D, Garon EB, Goldman J, Sollier E. Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients. Front Oncol 2020;10:572895. [PMID: 33117705 DOI: 10.3389/fonc.2020.572895] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
17 Ferreira D, Miranda J, Martins-Lopes P, Adega F, Chaves R. Future Perspectives in Detecting EGFR and ALK Gene Alterations in Liquid Biopsies of Patients with NSCLC. Int J Mol Sci 2021;22:3815. [PMID: 33916986 DOI: 10.3390/ijms22083815] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Lazzari C, Gregorc V, Cangi MG, Giovannetti E, Bulotta A, Santarpia M. Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer. J Thorac Dis 2018;10:S4023-7. [PMID: 30631545 DOI: 10.21037/jtd.2018.10.17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Rosas Plaza X, van Agthoven T, Meijer C, van Vugt MATM, de Jong S, Gietema JA, Looijenga LHJ. miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy. Cells 2019;8:E1221. [PMID: 31597402 DOI: 10.3390/cells8101221] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
20 Akhoundova D, Mosquera Martinez J, Musmann LE, Britschgi C, Rütsche C, Rechsteiner M, Nadal E, Garcia Campelo MR, Curioni-Fontecedro A. The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer. J Clin Med 2020;9:E3674. [PMID: 33207619 DOI: 10.3390/jcm9113674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Garrido P, Conde E, de Castro J, Gómez-Román JJ, Felip E, Pijuan L, Isla D, Sanz J, Paz-Ares L, López-Ríos F. Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Clin Transl Oncol 2020;22:989-1003. [PMID: 31598903 DOI: 10.1007/s12094-019-02218-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
22 Sahu SS, Cavallaro S, Hååg P, Nagy Á, Karlström AE, Lewensohn R, Viktorsson K, Linnros J, Dev A. Exploiting Electrostatic Interaction for Highly Sensitive Detection of Tumor-Derived Extracellular Vesicles by an Electrokinetic Sensor. ACS Appl Mater Interfaces 2021;13:42513-21. [PMID: 34473477 DOI: 10.1021/acsami.1c13192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Alam A, Ansari MA, Badrealam KF, Pathak S. Molecular approaches to lung cancer prevention. Future Oncol 2021;17:1793-810. [PMID: 33653087 DOI: 10.2217/fon-2020-0789] [Reference Citation Analysis]
24 Yang C, Guo X, Li J, Han J, Jia L, Wen H, Sun C, Wang X, Zhang B, Li J, Chi Y, An T, Wang Y, Wang Z, Li H, Li L. Significant Upregulation of HERV-K (HML-2) Transcription Levels in Human Lung Cancer and Cancer Cells. Front Microbiol 2022;13:850444. [DOI: 10.3389/fmicb.2022.850444] [Reference Citation Analysis]
25 Dong SW, Li R, Cheng Z, Liu DC, Xia J, Xu J, Li S, Wang J, Yue Y, Fan Y, Cao Y, Dai L, Wang J, Zhao P, Wang X, Xiao Z, Qiu C, Wang GS, Zou C. Mutational Pattern in Multiple Pulmonary Nodules Are Associated With Early Stage Lung Adenocarcinoma. Front Oncol 2020;10:571521. [PMID: 33680914 DOI: 10.3389/fonc.2020.571521] [Reference Citation Analysis]
26 Jin S, Zhou C, Hou X, Fan Z, Zhao J, Ai X, Chu Y, Chen R, Guo R, Chen L. A multicenter real-world study of tumor-derived DNA from pleural effusion supernatant in genomic profiling of advanced lung cancer. Transl Lung Cancer Res 2020;9:1507-15. [PMID: 32953522 DOI: 10.21037/tlcr-20-882] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Cook L, Starr K, Boonyaratanakornkit J, Hayden R, Sam SS, Caliendo AM. Does Size Matter? Comparison of Extraction Yields for Different-Sized DNA Fragments by Seven Different Routine and Four New Circulating Cell-Free Extraction Methods. J Clin Microbiol 2018;56:e01061-18. [PMID: 30282788 DOI: 10.1128/JCM.01061-18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
28 Pang B, Hu C, Xing N, Xu L, Zhang S, Yu X. Elevated Notch1 enhances interleukin-22 production by CD4+ T cells via aryl hydrocarbon receptor in patients with lung adenocarcinoma. Biosci Rep 2018;38:BSR20181922. [PMID: 30473538 DOI: 10.1042/BSR20181922] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lampignano R, Kloten V, Krahn T, Schlange T. Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future? Molecular Aspects of Medicine 2020;72:100844. [DOI: 10.1016/j.mam.2020.100844] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Raman L, Van der Linden M, Van der Eecken K, Vermaelen K, Demedts I, Surmont V, Himpe U, Dedeurwaerdere F, Ferdinande L, Lievens Y, Claes K, Menten B, Van Dorpe J. Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma. Genome Med 2020;12:35. [PMID: 32317009 DOI: 10.1186/s13073-020-00735-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Duan GC, Zhang XP, Wang HE, Wang ZK, Zhang H, Yu L, Xue WF, Xin ZF, Hu ZH, Zhao QT. Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer. Onco Targets Ther 2020;13:1931-9. [PMID: 32184628 DOI: 10.2147/OTT.S241956] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
32 Chang S, Hur JY, Choi YL, Lee CH, Kim WS. Current status and future perspectives of liquid biopsy in non-small cell lung cancer. J Pathol Transl Med 2020;54:204-12. [PMID: 32460474 DOI: 10.4132/jptm.2020.02.27] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Wadowska K, Błasiak P, Rzechonek A, Bil-Lula I, Śliwińska-Mossoń M. New Insights on Old Biomarkers Involved in Tumor Microenvironment Changes and Their Diagnostic Relevance in Non-Small Cell Lung Carcinoma. Biomolecules 2021;11:1208. [PMID: 34439874 DOI: 10.3390/biom11081208] [Reference Citation Analysis]
34 Tatischeff I. Current Search through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles. Int J Mol Sci 2021;22:5674. [PMID: 34073560 DOI: 10.3390/ijms22115674] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Rastogi A, Yadav K, Mishra A, Singh MS, Chaudhary S, Manohar R, Parmar AS. Early diagnosis of lung cancer using magnetic nanoparticles-integrated systems. Nanotechnology Reviews 2021;11:544-74. [DOI: 10.1515/ntrev-2022-0032] [Reference Citation Analysis]
36 Ning J, Ge T, Jiang M, Jia K, Wang L, Li W, Chen B, Liu Y, Wang H, Zhao S, He Y. Early diagnosis of lung cancer: which is the optimal choice? Aging (Albany NY) 2021;13:6214-27. [PMID: 33591942 DOI: 10.18632/aging.202504] [Reference Citation Analysis]
37 Wadowska K, Bil-Lula I, Trembecki Ł, Śliwińska-Mossoń M. Genetic Markers in Lung Cancer Diagnosis: A Review. Int J Mol Sci 2020;21:E4569. [PMID: 32604993 DOI: 10.3390/ijms21134569] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
38 Stiller C, Viktorsson K, Paz Gomero E, Hååg P, Arapi V, Kaminskyy VO, Kamali C, De Petris L, Ekman S, Lewensohn R, Karlström AE. Detection of Tumor-Associated Membrane Receptors on Extracellular Vesicles from Non-Small Cell Lung Cancer Patients via Immuno-PCR. Cancers (Basel) 2021;13:922. [PMID: 33671772 DOI: 10.3390/cancers13040922] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
39 Xu Q, Chen Y. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma. Front Cell Dev Biol 2021;9:685379. [PMID: 34277626 DOI: 10.3389/fcell.2021.685379] [Reference Citation Analysis]
40 Sadighbayan D, Sadighbayan K, Khosroushahi AY, Hasanzadeh M. Recent advances on the DNA-based electrochemical biosensing of cancer biomarkers: Analytical approach. TrAC Trends in Analytical Chemistry 2019;119:115609. [DOI: 10.1016/j.trac.2019.07.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
41 Maharjan N, Thapa N, Tu J. Blood-based Biomarkers for Early Diagnosis of Lung Cancer: A Review Article. JNMA J Nepal Med Assoc 2020;58:519-24. [PMID: 32827019 DOI: 10.31729/jnma.5023] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Zhao Q, Yuan Z, Wang H, Zhang H, Duan G, Zhang X. Role of circulating tumor cells in diagnosis of lung cancer: a systematic review and meta-analysis. J Int Med Res 2021;49:300060521994926. [PMID: 33682521 DOI: 10.1177/0300060521994926] [Reference Citation Analysis]
43 Isaksson S, George AM, Jönsson M, Cirenajwis H, Jönsson P, Bendahl PO, Brunnström H, Staaf J, Saal LH, Planck M. Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence. Acta Oncol 2019;58:1079-86. [PMID: 31230502 DOI: 10.1080/0284186X.2019.1610573] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
44 Garland SN, Irwin MR, Posner D, Perlis ML. Are sleep continuity disturbance and fatigue prodromal symptoms of cancer development? Med Hypotheses 2018;120:72-5. [PMID: 30220346 DOI: 10.1016/j.mehy.2018.08.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Shende P, Augustine S, Prabhakar B, Gaud RS. Advanced multimodal diagnostic approaches for detection of lung cancer. Expert Review of Molecular Diagnostics 2019;19:409-17. [DOI: 10.1080/14737159.2019.1607299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
46 Cavallaro S, Hååg P, Sahu SS, Berisha L, Kaminskyy VO, Ekman S, Lewensohn R, Linnros J, Viktorsson K, Dev A. Multiplexed electrokinetic sensor for detection and therapy monitoring of extracellular vesicles from liquid biopsies of non-small-cell lung cancer patients. Biosens Bioelectron 2021;193:113568. [PMID: 34428672 DOI: 10.1016/j.bios.2021.113568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
47 Baszuk P, Janasik B, Pietrzak S, Marciniak W, Reszka E, Białkowska K, Jabłońska E, Muszyńska M, Lesicka M, Derkacz R, Grodzki T, Wójcik J, Wojtyś M, Dębniak T, Cybulski C, Gronwald J, Kubisa B, Wójcik N, Pieróg J, Gajić D, Waloszczyk P, Scott RJ, Wąsowicz W, Jakubowska A, Lubiński J, Lener MR. Lung Cancer Occurrence-Correlation with Serum Chromium Levels and Genotypes. Biol Trace Elem Res 2021;199:1228-36. [PMID: 32648197 DOI: 10.1007/s12011-020-02240-6] [Reference Citation Analysis]
48 Lakshminarayanan H, Rutishauser D, Schraml P, Moch H, Bolck HA. Liquid Biopsies in Renal Cell Carcinoma-Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease. Front Oncol 2020;10:582843. [PMID: 33194717 DOI: 10.3389/fonc.2020.582843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Zeng D, Wang C, Mu C, Su M, Mao J, Huang J, Xu J, Shao L, Li B, Li H, Li B, Zhao J, Jiang J. Cell-free DNA from bronchoalveolar lavage fluid (BALF): a new liquid biopsy medium for identifying lung cancer. Ann Transl Med 2021;9:1080. [PMID: 34422992 DOI: 10.21037/atm-21-2579] [Reference Citation Analysis]